The largest database of trusted experimental protocols

1290 infinity 2 series

Manufactured by Agilent Technologies
Sourced in Germany

The Agilent 1290 Infinity II series is a high-performance liquid chromatography (HPLC) system designed for analytical and preparative applications. It offers advanced features and capabilities to support a wide range of laboratory workflows.

Automatically generated - may contain errors

7 protocols using 1290 infinity 2 series

1

Semi-preparative HPLC Purification Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A semi-preparative HPLC instrument (1290 infinity series II, Agilent Tech., Santa Clara, CA, USA) consisting of a degasser, quaternary pump, UV–Vis detector, thermostated autosampler, and oven, equipped with an automatic fraction collector, was used. The separation was performed on a Develosil diol column (250 mm × 10 mm, 5 μm) at 50 °C. The flow rate was set at 5 mL/min, and the injection volume was equivalent to 80 mg/load. The mobile phase was based on a previous work by Kelm et al. [48 (link)], using acetonitrile/acetic acid (98/2 v/v, A) and methanol/water/acetic acid (95/3/2 v/v, B). The optimal linear gradient applied was: 0 min, 10% B; 0.5 min, 12% B; 1.5 min, 12% B; 6.0 min, 18% B; 12.5 min, 35% B; 12.6 min, 100% B; 13.6 min, 100% B. Then, it was returned to the initial condition (10% B) and re-equilibrated for 10 min. The sample was dissolved in acetone/water/acetonitrile/acetic acid (60/29.5/10/0.5 v/v/v/v) and filtered through a 0.45-µm (Durapore PVDF, Millipore, USA) membrane. The thawed fractions were pooled and stored at −80 °C for less than 5 days. After that, collected samples were concentrated and stored as explained in Section 4.3.1. The relative composition of every fraction was determined by UHPLC-QTOF-MS method described in Section 4.4.
+ Open protocol
+ Expand
2

UPLC-PDA-MS Protocol for Reaction Yield Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Reactions were quenched by addition of 3 equivalents of methanol, then centrifugation at 17,000 × g for 10 min. The resulting supernatant was subjected to liquid chromatography PDA spectrometry (UPLC) analysis performed on an Agilent 6230 time of flight mass spectrometer with a Dual AJS ESI source and an Agilent 1290 Infinity Series II diode array detector, autosampler, and binary pump (phase A = 95:5 water:acetonitrile; phase B = 95:5 acetonitrile:water; 0.7 mL/min). Samples were loaded onto a Waters Acquity UPLC HSST3 column (1.8 μm C18, 2.1 × 50 mm) and resolved with the following gradient: hold at 30% B for 0.5 min, increase to 45% B over 1 min, hold at 100% B for 0.5 min. Ion chromatograms were generated in negative mode and extraction ion chromatogram (EIC) peak areas (±20 ppm) were were used to calculate the relative percent yield for a given reaction.
+ Open protocol
+ Expand
3

Quantification of Stilbenoids by UHPLC-UV

Check if the same lab product or an alternative is used in the 5 most similar protocols
For quantification of stilbenoids, a UHPLC system from Agilent Technologies (Waldbronn, Germany), with a high-speed pump (1290 Infinity II series), multicolumn thermostat (1290 Infinity II series), vialsampler (1290 Infinity II series), a diode array detector (1290 Infinity II series), and Open Lab CDS 3.4 (Agilent Technologies, Waldbronn, Germany) was used. The separation was achieved on a Zorbax Eclipse Plus C18 column (1.8 µm, 50 × 2.1 mm, Agilent Technologies, Waldbronn, Germany) according to Kiene and co-workers [35 (link)]. For this, the mobile phase consisted of water/acetonitrile/formic acid (100/10/0.1; v/v/v) (A) and acetonitrile (B). The separation was carried out at 60 °C with a flow rate of 0.4 mL/min, under the following conditions: 0 min (0% B), 1.73 min (0% B), 2.73 min (16% B), 6.2 min (45% B), 6.4 min (0% B), and 7.2 min (0% B). Trans-resveratrol was quantified at λ 306 nm and trans-ε-viniferin, r-2-viniferin, and r-viniferin were quantified at 324 nm, respectively. The quantification parameters of the UHPLC-UV methodology are listed in Supplementary Material Table S5.
+ Open protocol
+ Expand
4

UHPLC Peptide Purity Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For determination of purity by UHPLC, the filtered peptide solution was diluted in 10–50% acetonitrile (MeCN) in water with 0.1% TFA (500 μL) to a final concentration of approximately 0.5 mg/mL. The samples were analyzed on Agilent 1290 Infinity II Series, which was computer-controlled through Agilent OpenLab CDS and ChemStation software. For standard analysis of all peptide samples, analytical UHPLC spectra were recorded on an analytical Agilent Zorbax 300SB-C18 Rapid Resolution HD column (2.1 mm × 100 mm, 1.8 μm particle size) kept at 40 °C; elution at a flow rate of 0.8 mL/min with A: MeCN/H2O (5:95) + 0.1% TFA and B: MeCN/H2O (95:5) + 0.1% TFA, isocratic 0% B for 3 min; then 0–100% B over 20 min (ca. 4.5% MeCN/min) with UV detection at 214 nm and 120 points s−1. The total method time was 23.1 min. Then, the column was re-equilibrated using a post-run method at 0% Solvent B for 2 min. Purities of the final peptides were calculated by integration of the Area Under the Curve (AUC) of desired product peak as a percentage of the AUC of all peaks (within 3–18 min) at λ = 214 nm (amide backbone).
+ Open protocol
+ Expand
5

Pharmacokinetics of Compound 2l in Rats

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult male rats (N = 3/group) were administered with compound 2l dissolved in distilled water (tween 80) at a single dose of 10 mg/kg by oral administration and 10 mg/mL by injection. Serum samples were collected each 30 min. The blood concentration of the test compounds was determined by LC-MS/MS (Agilent 1290 infinity II series equipped with on-line degasser, binary pump, thermostatted well-plate autosampler and column compartment, Waters Atlantis® HSS T3 (2.1 × 100 mm, 1.9 µm) column, and mobile phase linear gradient from 95% A (0.1% formic acid in water) /5% B (0.1% formic acid in acetonitrile) to 5% A/95% B, 6500+ QTRAP LC-MS/MS/MS system, Turbo Spray Ion Drive as ion source, and Carbamazepine as internal standard. Pharmacokinetic parameters were obtained by non-compartmental analysis of the plasma concentration–time profiles using KineticaTM 4.4.1 (Thermo Fisher Scientific, Inc., Woburn, MA, USA).
+ Open protocol
+ Expand
6

Liquid Chromatography-Mass Spectrometry Analysis of Phenolic Compounds in Herbal Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HT-extracted CS was prepared using the optimal extraction conditions obtained from the OFAT approach. The liquid samples were dried using a freeze dryer and subjected to analysis by LC-quadrupole-time-of-flight mass spectrometer (LC-QTOF-MS). Identification of phenolic compounds and derivatives in HT-extracted CS was performed at the Science and Technology Research Institute, Chiang Mai University, Thailand [13 (link)]. The samples were analyzed using an Agilent 1290 Infinity II series coupled with a 6546 LC-QTOF instrument. Electrospray ionization (ESI) was used for ionization in negative mode. The nebulizer was operated at 35 psi with 11 L/min N2 flow. The capillary temperature was kept at 350 °C, while the sample flow rate was set at 0.2 mL/min. The m/z range was scanned within 100−1700, the capillary voltage was 3500 V, and the dry heater temperature was 320 °C. Provisional compound identification was performed by matching accurate mass results to content from the METLIN Personal Compound Database and Library (PCDL).
+ Open protocol
+ Expand
7

HPLC Analysis of Ascorbic Acid

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vitamin C content was determined using high performance liquid chromatography (HPLC) on an Agilent 1290 Infinity II Series (Germany) equipped with a degasser, quaternary pump, and autosampler injector set to a volume injection of 20 µL. Separation was carried out using a YMC-Triart C18 HPLC column (5 m particle size 150 4.6 mm I.D., maintained at 25°C) and a UV-Visible diode array detector (DAD). The mobile phase used were 0.015 mol/L potassium dihydrogen phosphate (KH 2 PO 4 ) buffer solution (pH: 2.6) and the ascorbic acid peaks were detected at 250 nm. The standard used in this analysis was L-ascorbic acid with five different concentration (10, 25, 50, 75, 100 mg/L) with equation y = 239.19x -294.14 and R² = 0.9984.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!